Furthermore, S31-201 treatment reduced the survival of RR-HEp-2 cells in response to various doses of radiation (Fig. 4C), indicating that STAT3 activity is essential for the radioresistance of laryngeal cancer cells. The gene discussed is STAT3; the disease is laryngeal carcinoma.